ID   KTCTL-30
AC   CVCL_5878
SY   KTCTL30; KTCTL 30; RCC-HS
DR   CLS; 300250
DR   Cosmic; 1352062
DR   Cosmic; 1751973
DR   Wikidata; Q54900646
RX   PubMed=8086765;
RX   PubMed=11762795;
RX   PubMed=11929824;
CC   Problematic cell line: Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
CC   Discontinued: CLS; 300250; true.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5871 ! KTCTL-2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
RX   PubMed=8086765; DOI=10.1007/BF00252823;
RA   Gross A.J., Wolff M., Fandrey J., Miersch W.-D., Dieckmann K.-P.,
RA   Jelkmann W.;
RT   "Prevalence of paraneoplastic erythropoietin production by renal cell
RT   carcinomas.";
RL   Clin. Investig. 72:337-340(1994).
//
RX   PubMed=11762795; DOI=10.1007/s002400100214;
RA   Siebels M., Meyer G., Habicht A., Meuer S.C., Moebius U.;
RT   "Simultaneous ligation of CD5 and CD28 with monoclonal antibodies
RT   restores impaired immunostimulatory function in human renal cell
RT   carcinoma.";
RL   Urol. Res. 29:330-337(2001).
//
RX   PubMed=11929824;
RA   Batrla R., Linnebacher M., Rudy W., Stumm S., Wallwiener D.,
RA   Guckel B.;
RT   "CD40-expressing carcinoma cells induce down-regulation of CD40 ligand
RT   (CD154) and impair T-cell functions.";
RL   Cancer Res. 62:2052-2057(2002).
//